Literature DB >> 6601709

HLA-DR antigens in progressive systemic sclerosis (scleroderma).

T L Whiteside, T A Medsger, G P Rodnan.   

Abstract

Typing at the HLA-DR locus was performed in 125 North American white patients with progressive systemic sclerosis (PSS). We could not confirm associations of PSS with the HLA-DR5 antigen or the HLA-B8/DR3 haplotype. A weak association of the DR1 antigen and PSS with diffuse scleroderma (27.5% vs 11.5% in local controls (corrected p less than 0.05) was observed. HLA-DR1 was significantly associated with the presence of anticentromere antibodies (p less than 0.05), and this combination was found more frequently in individuals with the CREST syndrome variant of PSS. This study failed to identify a clear-cut association between PSS and a genetic factor linked to the major histocompatibility complex.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601709

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 2.  Major histocompatibility complex class II genes and systemic sclerosis.

Authors:  D Briggs; K I Welsh
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Immunogenetic markers in rheumatic diseases.

Authors:  L Martin; M J Fritzler
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

4.  Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.

Authors:  P G Vlachoyiannopoulos; U G Dafni; I Pakas; M Spyropoulou-Vlachou; C Stavropoulos-Giokas; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

5.  Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses.

Authors:  A J Barnett; L J McNeilage
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

6.  The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).

Authors:  M Kuwana; J Kaburaki; Y Okano; H Inoko; K Tsuji
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis).

Authors:  A J Barnett; B D Tait; M A Barnett; B H Toh
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.